Delivery Order SPE2DB24D1007-SPE2DB24FBYYW

Award Date 3/27/24
Potential Completion Date 3/28/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office division. The Delivery Order, valued at $1,615.87, is for the provision of Xarelto 20 mg tablets (90-count) and is a firm-fixed price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, also holds a $999,999,999.00...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $7,579.59 and an ultimate completion date of January 28, 2022. It is a firm fixed-price delivery order contract, without any set-aside designations. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,635.19 firm fixed-price delivery order is for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award with a ceiling value of $13,610.66 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order for Xarelto 10 mg tablets. The award, which has an ultimate completion date of April 5, 2024, is not associated with any set-aside designations. Amerisourcebergen Drug Corporation is the prime contractor and is the sole awardee of an...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,843.28, has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $19,613.49 firm fixed price contract is for the supply of the pharmaceutical product Xarelto 20 mg tablet. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Xarelto 20 mg tablets. The $4,817.37 firm fixed-price delivery order has an ultimate completion date of October 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,819.82 Firm Fixed Price Delivery Order is for the supply of Xarelto 20 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $13,321.48, is for the delivery of Xarelto 20 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of September 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $3,696.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xarelto 15 mg tablets. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBYYW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $27,701.72, is for the delivery of Xarelto 20 mg tablets in 90-count packages. This is a firm fixed price delivery order contract that does not have a set-aside designation.

Amerisourcebergen Drug Corp, through its Corporate Office division, also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, with a period of performance through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide. The IDC was awarded solely to Amerisourcebergen Drug Corp as a single award contract.

Generated 6/26/24, 9:44 AM